KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 97 filers reported holding KRONOS BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76,066 | -9.9% | 52,100 | 0.0% | 0.00% | – |
| Q4 2022 | $84,402 | -48.2% | 52,100 | +7.0% | 0.00% | – |
| Q3 2022 | $163,000 | -3.6% | 48,700 | +5.2% | 0.00% | – |
| Q2 2022 | $169,000 | -40.7% | 46,300 | +17.5% | 0.00% | – |
| Q1 2022 | $285,000 | -46.6% | 39,400 | +0.3% | 0.00% | – |
| Q4 2021 | $534,000 | -35.2% | 39,300 | 0.0% | 0.00% | – |
| Q3 2021 | $824,000 | -12.4% | 39,300 | 0.0% | 0.00% | – |
| Q2 2021 | $941,000 | – | 39,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |